Scientists at Temple University have made a breakthrough in the fight against HIV by successfully applying CRISPR/Cas9 gene editing technology to remove HIV-1 DNA from the genomes of human immune cells. Unlike current treatments that suppress the virus, this approach completely eliminates the genetic code of HIV from infected T-cells.
The research, led by Dr. Kamel Khalili, showed that the virus could be effectively excised from latently infected cells, as confirmed in animal models, including mice and macaques. After treatment, the cells remained HIV-free, even after subsequent exposure to the virus. Additionally, no toxic or adverse effects were observed, indicating the safety of the method.
Based on these findings, researchers have developed an experimental therapy called EBT-101, which is currently undergoing clinical trials. If successful, it could lead to the first therapy in the world capable of fully curing HIV infection.
This scientific breakthrough raises new hopes in the global fight against HIV and may fundamentally transform how this disease is treated in the future.
